An established and profitable South Korean premium feminine intimate-care brand is available for a 100% share acquisition, including its owned manufacturing and operating facilities.
Founded as a brand in 2015 and incorporated in 2017, the company specializes in premium feminine care, skincare and wellness products. Its portfolio comprises 24 SKUs across six categories, supported by patented product technologies, direct-to-consumer sales channels and an established customer base.
Business Highlights
- FY2025 revenue of approximately USD 2.63 million and operating profit of USD 0.51 million.
- Operating profit margin of 19.5% in FY2025, improving for three consecutive years.
- Approximately 18,600 ordering customers recorded between December 2020 and November 2026.
- Approximately 3 million cumulative units sold as reported by the company in 2026.
- A 66% repeatpurchase rate among flagship serum customers.
- Direct online and directsales channels accounting for 86% of recorded customer payments.
- Portfolio of 24 products across intimate care, facial skincare, body care, wellness, beauty devices and salon products.
- Six registered productrelated patents, five of which are currently held by the CEO and are expected to be transferred to the company at closing.
- An owned factory and operating premises in Gyeonggi Province, South Korea.
Competitive Advantages
The company operates in the premium women's intimate-care market, with a differentiated product portfolio and patented technologies.
Its flagship premium serum supports strong customer loyalty. According to company order records, serum customers represent approximately 32% of customers but account for 79% of cumulative customer payments.
The company has received multiple consumer brand awards and maintains established direct-to-consumer and selected professional distribution channels.
Growth Opportunities
Potential expansion opportunities include increased digital marketing, customer reactivation, cross-selling into skincare and wellness products, expansion into overseas markets, and development of professional and B2B distribution channels.
Transaction Overview
The shareholder is offering 100% of the company's existing shares, including management control.
The indicative asking price is approximately USD 3.45 million, including the company's owned factory and related real estate.
Five registered patents currently held by the CEO are intended to be transferred to the company at closing, subject to agreed transaction documentation.
Further financial, operational and asset information will be provided to qualified buyers subject to confidentiality arrangements.
